Campbell Rogers sold $1.6M of HTFL
Chief Medical Officer at Heartflow, Inc.. 65,153 shares at an average of $24.49, traded Feb 12, 2026, filed Feb 17, 2026.
Score components
- +15RoleOfficer
- +25Trade size$1.6M at market
- +10Share of holdings soldSold 46% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +16.3%, 3m +19.4%, 6m +103.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001464521-26-000018, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | MOption exercise Common Stock10b5-1 | +19,401 | $2.22 | $43k | 93,572 | Feb 17, 2026 |
| Feb 12, 2026 | MOption exercise Common Stock10b5-1 | +39,709 | $8.33 | $331k | 133,281 | Feb 17, 2026 |
| Feb 12, 2026 | MOption exercise Common Stock10b5-1 | +7,906 | $2.22 | $18k | 141,187 | Feb 17, 2026 |
| Feb 12, 2026 | SOpen-market sale Common Stock10b5-1 | -65,153 | $24.49 | $1.6M | 76,034 | Feb 17, 2026 |
| Feb 12, 2026 | MOption exercise Stock Optionderivative10b5-1 | -39,709 | $0.00 | $0 | 0 | Feb 17, 2026 |
| Feb 12, 2026 | MOption exercise Stock Optionderivative10b5-1 | -19,401 | $0.00 | $0 | 216,433 | Feb 17, 2026 |
| Feb 12, 2026 | MOption exercise Stock Optionderivative10b5-1 | -7,906 | $0.00 | $0 | 208,527 | Feb 17, 2026 |
Related signals
Other insiders at Heartflow, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Heartflow, Inc. | Campbell Rogers Chief Medical Officer | $987k 19,682 shares | -20% | |
| 47Moderate | Heartflow, Inc. | Vikram Verghese Chief Financial Officer | $1.2M 24,345 shares | -14% | |
| 47Moderate | Heartflow, Inc. | Vikram Verghese Chief Financial Officer | $1.8M 34,975 shares | -16% | |
| 50Moderate | Heartflow, Inc. | John C.M. Farquhar Chief Executive Officer | $1.8M 38,900 shares | -11% | |
| 32Weak | Heartflow, Inc. | Vikram Verghese Chief Financial Officer | $332k 6,640 shares | -3% | |
| 40Moderate | Heartflow, Inc. | Vikram Verghese Chief Financial Officer | $1.7M 33,416 shares | -13% | |
| 45Moderate | Heartflow, Inc. | John C.M. Farquhar Chief Executive Officer | $1.4M 27,230 shares | -7% | |
| 38Weak | Heartflow, Inc. | John C.M. Farquhar Chief Executive Officer | $1.5M 32,676 shares | -8% | |
| 4Weak | Heartflow, Inc. | Campbell Rogers Chief Medical Officer | $380k 9,219 shares | -10% | |
| 33Weak | Heartflow, Inc. | John C.M. Farquhar Chief Executive Officer | $608k 15,560 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.